Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 2024390317
COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN
granted -
US 12150777
Treatment of depression
granted -
US 12145925
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 12144809
Treatment of prostate cancer
granted -
US 12146139
Oligonucleotide interference treatments of prostate cancer
granted -
US 12144801
Methods and compositions for treatment of epileptic disorders
granted -
US 12138247
Non-sedating dexmedetomidine treatment regimens
granted -
US 12138274
Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases
granted -
US 12139711
Antisense oligonucleotides for the treatment of Leber congenital amaurosis
granted -
US 12134767
Materials and methods for treatment of hemoglobinopathies
granted -
US 12134650
Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
granted -
US 12128015
APE/REF1 inhibitors for the treatment of cancer
granted -
US 12128013
Toxic aldehyde related diseases and treatment
granted -
US 12129471
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
granted -
US 12128048
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12128090
Methods of prophylactic treatment using recombinant VWF (rVWF)
granted -
US 12121288
Combination tumor treatment
granted -
US 12121503
Antiviral treatments
granted -
US 12122998
Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
granted -
US 12121523
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 12116405
Arthritis treatment
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12116574
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
granted -
US 12116589
Treatment of amyotrophic lateral sclerosis (ALS)
granted